GlassScriptPhysician profile
Nanette A Ortiz
NPI 1487637476
$1,810.59
in general payments reported to CMS, 2019-2025
15 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $127 · 2021: $183 · 2022: $257 · 2023: $588 · 2024: $82.29 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $344.00 | 2019-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $314.63 | 2019-2023 | Xarelto |
| Lilly USA, LLC | $275.87 | 2021-2023 | Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $221.33 | 2019-2023 | Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $202.51 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $90.01 | 2020 | |
| Abbott Laboratories | $87.77 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $51.70 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.27 | 2019-2023 | Jardiance |
| Amgen INC. | $43.71 | 2019-2022 | |
| Abbvie INC. | $40.27 | 2021-2022 | |
| Pfizer INC. | $40.23 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.98 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.11 | 2019 | |
| Mylan Specialty L.P. | $13.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nanette Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.